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The time of prenatal immune challenge determines the
specificity of inflammation-mediated brain and behavioral
pathology
Abstract
Disturbance to early brain development is implicated in several neuropsychiatric disorders including
autism, schizophrenia, and mental retardation. Epidemiological studies have indicated that the risk of
developing these disorders is enhanced by prenatal maternal infection, presumably as a result of
neurodevelopmental defects triggered by cytokine-related inflammatory events. Here, we demonstrate
that the effects of maternal immune challenge between middle and late gestation periods in mice are
dissociable in terms of fetal brain cytokine responses to maternal inflammation and the pathological
consequences in brain and behavior. Specifically, the relative expression of pro- and anti-inflammatory
cytokines in the fetal brains in response to maternal immune challenge may be an important determinant
among other developmental factors for the precise pathological profile emerging in later life. Thus, the
middle and late gestation periods correspond to two windows with differing vulnerability to adult
behavioral dysfunction, brain neuropathology in early adolescence, and of the acute cytokine responses
in the fetal brain.
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Disturbance to early brain development is implicated in several neuropsychiatric disorders including autism, schizophrenia, andmental
retardation. Epidemiological studies have indicated that the risk of developing these disorders is enhanced by prenatal maternal infec-
tion, presumably as a result of neurodevelopmental defects triggered by cytokine-related inflammatory events. Here, we demonstrate
that the effects of maternal immune challenge between middle and late gestation periods in mice are dissociable in terms of fetal brain
cytokine responses tomaternal inflammation and the pathological consequences in brain and behavior. Specifically, the relative expres-
sion of pro- and anti-inflammatory cytokines in the fetal brains in response to maternal immune challenge may be an important
determinant among other developmental factors for the precise pathological profile emerging in later life. Thus, the middle and late
gestation periods correspond to twowindowswith differing vulnerability to adult behavioral dysfunction, brain neuropathology in early
adolescence, and of the acute cytokine responses in the fetal brain.
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Introduction
Maternal bacterial and viral infections during pregnancy repre-
sent a risk factor in several neuropsychiatric disorders with a
presumed neurodevelopmental origin, including schizophrenia
(Mednick et al., 1988; O’Callaghan et al., 1994; Brown et al.,
2004b), autism (Rodier and Hyman, 1998; Miller et al., 2005),
and mental retardation (Rantakallio and von Wendt, 1985; Rev-
ello and Gerna, 2004). Although the mechanisms underlying this
epidemiological relationship remain unclear, the maternal
cytokine-associated inflammatory response to infection may be
the crucial link, because the identity of the pathogen seems irrel-
evant (Gilmore and Jarskog, 1997; Buka et al., 2001; Pearce, 2001;
Brown et al., 2004a). Similar inflammatorymechanisms have also
been suggested to underlie the association of chorioamnionitis
and the development of cerebral palsy (Dammann and Leviton,
1997, 2000; Wu and Colford, 2000; Wu, 2002). Animal experi-
mentation has also confirmed that, in the absence of a pathogenic
agent, cytokine-releasing treatment to pregnant mothers is suffi-
cient to inducemultiple psychopathology in the offspring later in
adulthood (Shi et al., 2003; Zuckerman et al., 2003; Meyer et al.,
2005, 2006).
In addition to their immunological roles (Curfs et al., 1997),
cytokines canmodulate neuronal survival (Marx et al., 2001) and
differentiation (Ling et al., 1998; Potter et al., 1999), as well as
dendrite growth and complexity (Gilmore et al., 2004), thereby
exerting multiple effects on the developing CNS. Intense eleva-
tion of inflammatory cytokine levels in the fetal environment
may therefore adversely affect neurodevelopment and contribute
to disease processes implicated in schizophrenia, autism, and
mental retardation. However, direct evidence for this causal link
is lacking, and themechanismswhereby infection-induced eleva-
tion of cytokine levels during fetal life can interfere with neuro-
developmental events remain poorly understood.
The functioning of thematernal host’s immune system exhib-
its considerable fluctuations as pregnancy progresses (Sargent,
1993). The associated changes in cytokine responses to an immu-
nological challenge may therefore critically modulate the speci-
ficity of inflammatory events in the developing fetus and thus
allow the dissection of the relative potentials of different species
of cytokines to precipitate brain mal-development and related
aberrations in behavior and cognition emerging in later life. At
the same time, this suggests that the developing nervous system
may not be uniformly vulnerable to maternal infection through-
out gestation. Indeed, epidemiological data suggest thatmaternal
infection during early-to-mid human pregnancy is more likely to
be associated with long-term developmental brain and behav-
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ioral abnormality in the offspring (Mednick et al., 1988; Rodier
and Hyman, 1998; Brown et al., 2004b).
Here, an intense but time-limited inflammatory cytokine
response in pregnant mouse dams was induced by an acute
systemic challenge of the viral mimic polyriboinosinic-
polyribocytidilic acid (PolyI:C), a synthetic analog of double-
stranded RNA (Fortier et al., 2004). It was conducted in pregnant
mouse dams on gestation day 9 (GD9) or GD17 at a proven
functionally effective dose (Meyer et al., 2005, 2006). The two
gestation days selected here correspond to the first-to-second and
second-to-third trimesters of human pregnancy, respectively,
with respect to developmental biology and percentage of gesta-
tion from mice to human (Kaufman, 2003).
Materials andMethods
Animals
Female and male C57BL6/J breeders were ob-
tained from our in-house specific pathogen-
free colony at the age of 10–14 weeks. Litter-
mates of the same sex were kept in groups of
three to fivemice. Breeding began after 2weeks of
acclimatization to the new animal holding room.
The breeding procedure and the verification of
pregnancy have been fully described previously
(Meyer et al., 2005). All procedures described in
the present study had been approved previously
by the Zurich Cantonal Veterinary Office and are
in agreementwith thePrinciples of LaboratoryAn-
imal Care (National Institutes of Health publica-
tion number 86-23, revised 1985).
Prenatal treatment
Pregnant dams onGD9orGD17 received either
a single injection of PolyI:C or vehicle solution
via the intravenous route at the tail vein under
mild physical constraint. PolyI:C (potassium
salt) was obtained from Sigma-Aldrich (Buchs,
St. Gallen, Switzerland) and dissolved in saline
to obtain the desired dosage (5 mg/kg, calcu-
lated based on the pure form PolyI:C). The vol-
ume of injection was 5 ml/kg. All animals were
immediately returned to the home cage after
the injection procedure. A group of pregnant
dams were left untreated throughout preg-
nancy, which served as an additional control
group for the behavioral experiments.
For the purpose of assessing the acute effects
of PolyI:C administration on the cytokine pro-
tein levels in thematernal serum and fetal brain
tissue, as well as on the relative gene expression
levels in the fetal brain, PolyI:C- or vehicle-
treated pregnant dams were killed by decapita-
tion 3 or 6 h after treatment. Trunk blood was
collected into Eppendorf (Hamburg,Germany)
tubes, and fetal brains were extracted under vi-
sual guidance using a dissecting microscope
(Stemi 2000-C; Zeiss, Oberkochen, Germany)
as described previously (Meyer et al., 2005).
Trunk blood was allowed to clot at room tem-
perature for 1 h before centrifugation at 12,000
rpm for 4min at 4°C. The resulting serum from
each animal was subdivided to permit storage
(80°C) until the cytokine assays were per-
formed. The brain samples collected for the
cytokine protein assay were stored at 80°C
until further processing. Fetal brain samples
assigned to the gene expression assays were
processed immediately after tissue collection
(see below).
Cytokine protein assays
Fetal brain samples were placed in 10 vol of Tris-HCl buffer (50 mM, pH
7.4) withNaCl (0.6 M), Triton X-100 (0.2%), and BSA (0.5%) containing
freshly dissolved protease inhibitors: benzamidine (1 mM), benzetho-
nium chloride (0.1 mM), and phenylmethylsulfonyl fluoride (0.1 mM).
Samples were homogenized (TissueTearor; BioSpec Products, Bartles-
ville, OK) for 10 s, sonicated (Vibra Cell; Sonics & Materials, Newtown,
CT) for 20 s at 10 mV, and centrifuged at 12,000 rpm for 20 min at 4°C.
The supernatants were aliquoted and frozen at80°C until the cytokine
assays were performed.
Cytokine protein levels in the maternal serum and fetal brain tissue
were measured using a multiplexed particle-based flow cytometric cyto-
kine assay (Vignali, 2000). Fluorokine MAP (Multi Analyte Profiling)
Figure 1. Middle but not late prenatal immune challenge suppresses explorative behavior in adulthood. a, Adultmice born to
PolyI:C-exposedmothers on GD9 showed a significant deficit in exploratory behavior comparedwith control offspring, as evident
by the reduction in the frequency to enter the central area in the open field. This effect was not observed in animals born to
PolyI:C-treated mothers on GD17. *p 0.05, statistical significance based on Fisher’s LSD post hoc comparison. b, No group
difference in basal locomotor activity was revealed, therefore the suppression of spatial exploration in GD9-PolyI:C offspring
cannot be attributed to any changes in general locomotor activity. c, The three panels illustrate the representative pattern of
spatial exploration of the three groups in the entire open field (top row) and in the central area (bottom row).n10 (5males and
5 females) in each treatment group. All values are mean SEM. Cntr, Control.
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mouse kits for interleukin 1 (IL-1), IL-6, IL-10, and tumor necrosis
factor  (TNF-) were purchased from R & D Systems (Wiesbaden-
Nordenstadt, Germany). The procedures closely followed the manufac-
turer’s instructions. The analysis was conducted using a conventional
flow cytometer (CyanADP;DakoCytomation, Glostrup, Denmark). The
detection limits were 2.7 pg/ml for IL-1, 0.1 pg/ml for IL-6, 0.5 pg/ml
for IL-10, and 0.4 pg/ml for TNF-.
Cytokine gene expression assays
Fetal brain samples were placed into Trizol (Invitrogen, Basel, Switzerland),
homogenizedwithaTissueTearor (BioSpecProducts), and storedat80°C.
Total RNA was isolated later according to the manufacturer’s instructions.
TheRNAwasDNase I treated and furtherpurifiedonRNeasyMicrokit spin
columns (Qiagen, Hombrechtikon, Switzerland). Total RNA was reverse
transcribed with Moloney murine leukemia virus reverse transcriptase (In-
vitrogen) and randomhexamerprimers (Invitrogen).Gene expressionanal-
ysis using Taqman gene expression assays (Applied Biosystems, Rotkreuz,
Switzerland) for IL-1 (Mm00434228_m1), IL-6 (Mm00446190_m1),
IL-10 (Mm439616_m1), TNF- (Mm00443258_m1), and 18S rRNA
(#4319413E) was performed on an Applied Biosystems (Foster City, CA)
7500 Real-Time PCR. Relative gene expression was calculated according to
the 2-CT method (Livak and Schmittgen, 2001).
Immunohistochemistry
At the age of 24 d, eight PolyI:C-exposed (four per sex) and four control
(saline injected, two per sex) mice were anesthetized with an overdose of
sodium pentobarbital (5 mg/kg) and perfused transcardially with 4%
phosphate-buffered paraformaldehyde solution with picric acid. They
were postfixed overnight and cryoprotected in 30% sucrose solution for
48 h at 4°C. Sections (30mthick)were cut coronally from frozen blocks
with a sliding microtome, and five serial sections from bregma 2.20 to
3.80 mm were collected, rinsed in PBS, and stored at 20°C in anti-
freeze until further processing.
For immunostaining, the slices were rinsed three times for 10 min in
PBS. Blocking was done in PBS, 0.3% Triton X-100, and 5% normal
serum for 1 h at room temperature. The following primary antibodies
were used: horse anti-doublecortin (DCX) (1:1000; Santa Cruz Biotech-
nology, Santa Cruz, CA), rabbit anti-cleaved caspase-3 (1:600; Cell Sig-
naling Technology, Beverly, MA), rabbit anti-GFAP (1:5000; DakoCyto-
mation), andmouse anti-Reelin (1:700; Chemicon, Temecula CA). They
were diluted in PBS containing 0.3%TritonX-100 and 2%normal serum
and incubated overnight at room temperature. After three washes with
PBS (10 min each), the sections were incubated for 1 h with the biotin-
ylated secondary antibodies diluted 1:500 in PBS containing 2% normal
serum and 0.3% Triton X-100. Sections were washed again three times
for 10 min in PBS and incubated with the Vectastain kit (Vector Labora-
tories, Burlingame, CA) diluted in PBS for 1 h. After three rinses in 0.1 M
Tris-HCl, pH 7.4, the sections were stained with 1.25% 3,3-
diaminobenzidine and 0.08% H2O2 for 8–20 min, rinsed again four
times in PBS, dehydrated, and coverslipped with Eukitt (Kindler,
Freiburg, Germany). The GFAP-labeled slices were counterstained with
0.25% cresyl violet according to standard protocols. After staining, the
sections were dehydrated through an alcohol series, cleared with xylene,
and coverslipped with Eukitt.
Densitometry
All analyses were performed blind to the treatment and gender classifi-
cation of the animals included in the study. Fifteen coronal brain sections
per animal were analyzed with a Zeiss Axioplan microscope, and digital
images of the DCX stainings were acquired using a digital camera (Axio-
cam; Zeiss). Exposure times were set so that pixel brightness was never
saturated andwere held constant during acquisition of all images for each
experiment. Densitometry measurements of the DCX immunoreactivity
were performed using ImageJ software (National Institutes of Health,
Bethesda, MD). Pixel brightness was measured in the subgranular and
outer granular cell layer of both blades of the dentate gyrus and the
corpus callosum (serving as background area) by placing a rectangular
box of 100 100 pixels in the respective area. The background-corrected
optical densities obtained from both brain hemispheres were averaged
per animal.
Stereological estimation of Reelin-positive neuron
The total number of Reelin-positive neurons in the CA1 stratum oriens
and dentate gyrus molecular layer of both hemispheres was determined
using the optical fractionator method (Gundersen et al., 1988). With the
aid of the image analysis computer software Stereo Investigator (version
6.50.1; Microbrightfield, Colchester, VT), every section of a one-in-five
series wasmeasured, resulting in an average of 12–15 sections per animal.
The following sampling parameters were used: (1) a fixed counting frame
with a width of 50mand a length of 50m; and (2) a sampling grid size
of 250  250 m. The counting frames were placed randomly at the
intersections of the grid within the outlined structure of interest by the
software. The cells were counted following the unbiased sampling rule
(Howard and Reed, 2005) using the 40 oil lens [numerical aperture
(NA), 1.3] and included in the measurement when they came into focus
within the optical dissector (height, 10 m). For the analysis, total esti-
mated Reelin-positive neurons were taken into account for each animal.
Counting of caspase-3-positive neurons
Cleaved caspase-3-positive cells in the dentate gyrus were counted ex-
haustively on both hemispheres of seven to nine stained sections per
Figure 2. Emergence of perseverative behavior after late but not mid pregnancy immune
challenge. Neither GD9-PolyI:C nor GD17-PolyI:C treatment affected the acquisition of a left–
right discrimination task, as evident by both themeasures of error to criterion (a) and percent-
age correct (b) on successive training days. A clear selective deficit in the GD17-PolyI:C group
emerged in the subsequent reversal training, indicating a perseverative phenotype. A reversal effect
wasevident inallgroupsas suggestedbythebelow-chanceperformance (representedbythedashed
line)onthefirstdayofreversal learning(b).Thereversaleffectpersistedintotheseconddayofreversal
training in the GD17-PolyI:C group but not the other treatment conditions. n 9 (males) in each
treatmentgroup.All values aremeanSEM.*p0.05, **p0.01, and***p0.001, statistical
significance based on Fisher’s LSDpost hoc analysis. Cntr, Control.
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animal using live microscopy with a 10 objective (NA, 0.45). Cell
counts were averaged per hemisphere and animal.
Behavioral assays
The offspringwereweaned and sexed at postnatal day 24 (P24). The pups
were weighed, and littermates of the same sex were caged separately and
maintained as described previously (Meyer et al., 2005). Behavioral test-
ing commenced when they reached 14–16 weeks of age. Each prenatal
treatment group consisted of subjects derived from multiple indepen-
dent litters (at least five in each treatment condition).
Open-field exploration. The apparatus comprised four identical 40 
40 cm2 rectangular white arenas. Data collection was performed using
the Ethovision tracking system (Noldus Information Technology,
Wageningen, The Netherlands) as described previously (Meyer et al.,
2005). To begin, the animals were gently placed in the center of the arena
and allowed to explore for 1 h. For the purpose of data collection, the
arena was conceptually partitioned into two zones: a center zone (mea-
suring 13.5 13.5 cm2) in themiddle of the arena and a peripheral zone
occupying the remaining area. Offspring of both sexes were included in
the open-field exploration test.
Discrimination reversal learning. The apparatus consisted of a modified
white circular tank measuring 1 m in diameter. It was filled daily with fresh
water to a depth of 19 cm, with the temperature of the water maintained at
24°C.OpaquePlexiglas partitionswerepositionedvertically into thewater
to form three interconnected corridors (10 cm wide) in the shape of a “T.”
The partition walls extended to a height of 18 cm above the water surface.
The vertical start armwas 30 cm long, and the two parallel choice armswere
45 cm long. They joined at the center of the water
tank. A piece of cylindrical clear Plexiglas, 7 cm in
diameter and 18.5 cm high, was positioned at the
end of either the left or right goal arm and served
as the escape platform.
In acquisition training, the animals were re-
quired to learn to discriminate the left and right
goal arms, with only one of them leading to an
escape platform hidden at the far end. For one-
half of the animals in each group, the left arm
was correct, and for the others, the right arm
was correct. The platform location remained
unchanged until the end of acquisition. There
were six trials per daily session, conducted at an
intertrial interval of 10min. To begin a trial, the
animalswere placed at the beginning of the start
arm and allowed up to 1min to choose between
the two goal arms. Once its entire body had
entered into an arm, a guillotine door was low-
ered to prevent the animal from retracing. If the
animal chose the correct arm, it was allowed to
remain on the platform for 10 s, after which it
was removed from the maze and returned to a
holding cage. When the incorrect arm was cho-
sen, the animalwas confined to the arm for10
s and then removed from the maze to a holding
cage. Acquisition training continued until an
animal had reached criterion performance of 11
correct responses across 2 consecutive days
(i.e., of 12 trials). Afterward, the platform loca-
tion was moved to the other, previously incor-
rect, arm to assess reversal learning. Reversal
training continued until an animal reached
criterion performance once again. The per-
centage of correct arm choices as well as er-
rors to criterion performance were recorded
for each animal during acquisition and rever-
sal training. Only male offspring were tested
in the discrimination reversal learning para-
digm, because of excessive floating behavior
in the female mice.
Statistical analysis
Behavioral and immunohistochemical as well as maternal serum cyto-
kine data were analyzed using parametric ANOVA, followed by Fisher’s
LSD post hoc comparisons whenever amain effect or interaction attained
statistical significance. Fetal brain cytokine protein and gene expression
data were analyzed using independent Student’s t tests (two-tailed). Sta-
tistical significance was set at p  0.05. Analyses were conducted using
the statistical software StatView (version 5.0) implemented on a personal
computer running theWindows XP operating system. Equal numbers of
offspring born to vehicle-treated and nontreated dams were com-
bined into a single control group in the final analysis and in the
presentation of the behavioral results after confirmation that they did
not differ from each other in terms of these measures (see also Meyer
et al., 2005, 2006). The factor sex was also dropped to enhance statis-
tical power in all the immunohistochemical analyses because it never
attained significance.
Results
Dissociating the adult psychopathology after prenatal
immune activation at middle and late pregnancy
The effects of prenatal immune challenge on behavior are ex-
pected to achieve their prominence when the affected individuals
reach adult age (Zuckerman et al., 2003).Here, we show thatGD9
but not GD17 prenatal immune activation reduced open-field ex-
ploration (Fig. 1), whereas GD17 but not GD9 immune activation
led to perseverative behavior (Fig. 2).
Figure3. Enhanced sensitivity to inflammation-mediateddisturbances inpostnatal Reelin expression in thebrainsof offspring
after mid-pregnancy immune challenge. a– c, Distribution of Reelin-immunoreactive cells in the hippocampal formation and
dentate gyrus of representative control animals (a) and animals subjected to prenatal PolyI:C exposure on GD9 (b) or GD17 (c). As
evident in the imagesat ahighermagnification (indicatedby the square ina), prenatal PolyI:C exposure affectedReelin expression
particularly in the stratum oriens (sto) of the CA1 subfield. The arrows in b indicate the lack of Reelin-positive cells in the entire
stratum oriens of GD9-Polyl:C offspring. e, g, This effect was particularly pronounced GD9-PolyI:C-exposed animals (e) relative to
controls (d), leading to a significant reduction inReelin-positive cells in thebrains of GD9-PolyI:C offspring comparedwith controls
(g). f, Prenatal PolyI:C exposure onGD17only resulted in amarginal reduction inpostnatal Reelin immunoreactivity.n4 in each
treatmentgroup. The values ingaremeanSEM. *p0.05, statistical significancebasedonFisher’s LSDpost hocanalysis. Scale
bars: a– c, 500m; d, e, 50m. Cntr, Control; sto, stratum oriens; str, stratum radiatum; pcl, pyramidal cell layer.
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First, we analyzed the spatial explora-
tion in an open field by focusing on the
number of entries the animals ventured
into the central area of the field during a 1 h
test period. Animals in the GD9-PolyI:C
group showed a marked reduction in this
measure that is most obvious in the second
half of the test. The effect of GD17-PolyI:C
treatment on this measure was weak by
comparison and statistically nonsignifi-
cant (Fig. 1a,c). A 2 3 6 (sex treat-
ment  10 min bins) split-plot ANOVA
yielded a significant main effect of treat-
ment (F(2,24)  3.82; p  0.05) and its in-
teraction with bins (F(10,120)  2.01; p 
0.05). Post hoc comparisons confirmed
that only the GD9-PolyI:C group dif-
fered significantly from offspring born to
control dams ( p  0.05). This specific
effect of GD9-PolyI:C treatment cannot be
attributed to any changes in overall locomo-
tor activity, because the total distance trav-
eled in the open field never differed among
groups (Fig. 1b). This represents a robust effect of mid- but not
late-pregnancy immune activation (Shi et al., 2003; Meyer et al.,
2005).
Second, the same animals were tested on discrimination re-
versal learning using a water T-maze. After learning to swim to
one of the two stems of the T-maze to escape from the water, the
animals were then required to learn to swim to the previously
inescapable stem.Adeficit in the second reversal phase, but not in
the first acquisition phase, is indicative of perseverative behavior,
as implicated in schizophrenia, autism, obsessive compulsive dis-
orders, and addictive behavior (Ridley, 1994). Behavioral perse-
veration was only evident in the GD17-PolyI:C group but not the
GD9-PolyI:C group. GD17-PolyI:C animals were uniquely im-
paired in the reversal phase (Fig. 2a, right). One-way ANOVA of
the number of errors to criterion in the reversal phase yielded a
clear main effect of treatment (F(2,24)  4.47; p  0.05) that is
solely attributed to the perseverative performance of the GD17-
PolyI:C group compared with the control ( p 0.05) and GD9-
PolyI:C ( p 0.001) groups. No group difference was detected in
the equivalentmeasure at the first acquisition phase (Fig. 2a, left),
supporting the interpretation that the effect of GD17-PolyI:C
treatment did not stem from a general learning deficit. A similar
pattern of results is also obtained in the analyses of the daily
performance in terms of choice accuracy (Fig. 2b). This illustrates
that although the initial impact of reversal was comparable
among the three groups, its influence on choice behavior re-
mained in the GD17-PolyI:C group for another day while the
other two groups were adapting to the reversed contingency.
Analysis of the percentage of correct choice across the 5 d of
reversal training yielded a significant main effect of treatment
(F(2,24) 4.41; p 0.05) and its interaction with days (F(8,96)
3.91; p 0.001). Additional analyses on successive training days
indicated that the GD17-PolyI:C group performed at a level sig-
nificantly below that of the others (F(2,24)  6.29; p  0.01; post
hoc, p0.01).
Differential neuropathology in early adolescence after
prenatal inflammation onmiddle and late gestation
The dissociable behavioral outcomes between middle and late
prenatal immune activation confirm our expectation that prena-
tal immune challenge at distinct prenatal times can differentially
compromise the integrity of specific functional neural circuitries.
To seek direct evidence for this hypothesis, we examined putative
changes at the neuroanatomical level in brains collected from
juvenile offspring (killed on P24) born to mothers treated with
PolyI:C or vehicle onGD9orGD17. Immunohistochemical anal-
yses of three relevant markers are reported here.
First, we examined the expression of Reelin immunoreactivity
because human postmortem studies have shown that reduced
Reelin expression is associated with several neuropsychiatric dis-
orders with a presumed neurodevelopmental origin (Fatemi,
2005). Prenatal PolyI:C exposure markedly reduced the number
of hippocampal Reelin-positive cells, but this effect was more
severe when the PolyI:C exposure took place at mid-pregnancy
(Fig. 3). Stereological analyses in the hippocampus revealed a
significant group difference in the number of Reelin-
immunoreactive cells in stratumoriens of the dorsal CA1 subfield
(F(2,9) 5.27; p 0.05). Subsequent post hoc comparisons veri-
fied that this stemmed from a significant reduction in the GD9-
PolyI:C group ( p  0.05) and a nonsignificant trend in the
GD17-PolyI:C group, relative to control levels.
Although the number of Reelin-positive cells in the dentate
gyrus was virtually unaffected by the prenatal treatment (means
SEM:control, 19,101.492142.8;GD9-PolyI:C, 15,295.92291.9;
GD17-PolyI:C, 19,419.8 1546.5), the Reelin immunoreactivity in
theneuropil throughout the hippocampal formation appeared to be
generally reduced in PolyI:C-treated subjects compared with con-
trols (Fig. 3a–c). Considering that Reelin is involved in fetal and
postnatal neural development by acting as a positioning anddetach-
ment signal for neurogenesis (Hack et al., 2002), the reduction in
Reelin-positive cells in theCA area aswell as the putative decrease in
theamountof secretedprotein inother subfieldsof thehippocampal
formation suggest that these alterations might be accompanied by
changes in the number of neuronal progenitor cells in the hip-
pocampus. Indeed, using an antibody againstDCX to visualize neu-
ronal progenitor cells (Brownet al., 2003) in thedentate gyruswhere
postnatal/adult neurogenesis is most abundant, we further revealed
that the levelsofnewlybornneurons in thedorsaldentate gyruswere
reduced in offspring born to PolyI:C-treated dams independent of
prenatal treatment times (Fig. 4). These impressionswere supported
Figure 4. Reduction in postnatal neurogenesis in the dentate gyrus after prenatal immune challenge. a, c, e, Photomicro-
graphs of coronal brain sections of the hippocampal formation and dentate gyrus were taken from representative control off-
spring (a) and animals subjected to prenatal PolyI:C exposure on GD9 (c) or GD17 (e) and visualized with immunoperoxidase
staining using anti-DCX antibody. b, d, f, As evident in the images at a highermagnification (indicated by the squares in a, c, and
e), reduced DXC relative optical density was observed in both the outer granule cell layer and the subgranular cell layer of the
dentate gyrus after prenatal PolyI:C exposure, and this effect was primarily independent of prenatal treatment times. The values
in g aremean SEM. *p 0.05 and **p 0.01, statistical significance based on Fisher’s LSD post hoc analysis. Scale bars: a, c,
e, 500m; b, d, f, 50m. Cntr, Control; ogcl, outer granule cell layer; gcl, granule cell layer; sgcl, subgranular cell layer.
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by themain effects of prenatal treatment attaining statistical signifi-
cance in theANOVAs conductedon thedensitometric evaluationof
DCX immunoreactivity in the subgranular (F(2,9) 5.11; p 0.05)
and outer granule (F(2,9) 7.34; p 0.05) cell layers of the dentate
gyrus. Subsequentposthocanalysesalso showedthat the reduction in
DCX immunoreactivity in GD9-PolyI:C offspring was statistically
significant in both the subgranular ( p  0.05) and outer granule
( p  0.01) cell layers compared with control offspring, whereas
prenatal PolyI:C exposure on GD17 particularly reduced postnatal
neurogenesis in theouter granule cell layer of thedentate gyrus ( p
0.05) relative to prenatal control treatment (Fig. 4g).
The concomitant reduction in levels of Reelin and neurogen-
esis led us to speculate that they could be related to a putative
increase in apoptotic cell loss in these juvenile offspring from
PolyI:C-treated dams. Apoptotic cells were visualized by the im-
munostaining of activated caspase-3, a cysteine protease and a
key degradative enzyme involved in apoptosis (Rami et al., 2003).
Quantitative analysis of activated caspase-3- immunoreactive
cells in the dentate gyrus granule cell layer indicated that in-
creased apoptotic activity was exclusively found in offspring from
the GD17-PolyI:C group (Fig. 5). This impression was supported
by the main effect of prenatal treatment in the ANOVA of this
measure (F(2,9)  4.37; p  0.05) and the subsequent post hoc
comparisons revealing a statistically significant difference be-
tween offspring subjected to prenatal PolyI:C exposure on GD9
and GD17 ( p  0.05). The number of caspase-3-
immunoreactive cells was, if anything, reduced in the GD9-Poly
group, albeit nonsignificantly so (Fig. 5d).
Consistent with our previous observations (M. Nyffeler, U.
Meyer, B. K. Yee, J. Feldon, and I. Knuesel, unpublished results),
prenatal PolyI:C treatment did not alter the overall morphology
of the hippocampus, nor did it induce cell necrosis and reactive
gliosis as confirmed by the qualitative evaluation of pyknotic cells
or astrocytes (Fig. 6).
Divergent cytokine reactions to maternal immune challenge
at middle and late gestation by the maternal host and
the fetus
Next, we analyzed cytokine events taking place in the maternal
serum and fetal brain at the time of maternal immune stimula-
tion by contrasting the cytokine response induced by maternal
PolyI:C treatment on GD9 and GD17 at two different sampling
intervals (3 and 6 h after treatment). We focused here on IL-1,
IL-6, IL-10, and TNF- because of their crucial roles inmodulat-
ing neuronal cell differentiation (Ling et al., 1998; Potter et al.,
1999) and survival (Marx et al., 2001), as well as dendrite growth
and complexity (Gilmore et al., 2004).
Maternal serum protein levels
As expected, the exposure to PolyI:C markedly increased the se-
rum protein levels of the four cytokines in both gestation day
conditions (Fig. 7), and these effects were generally more pro-
nounced at 3 h after treatment (Fig. 7a) compared with the latter
sampling interval at 6 h after treatment (Fig. 7b). These impres-
sions were supported by the emergence of significantmain effects
of treatment (IL-1: F(1,28) 6.23, p 0.05; IL-6: F(1,28) 40.97,
p 0.001; IL-10: F(1,28) 16.46, p 0.001; TNF-: F(1,28) 5.06,
p  0.05) and their interactions with sampling time (IL-1:
F(1,28) 6.23, p 0.05; IL-6: F(1,28) 36.46, p 0.001; TNF-:
F(1,28)  4.78, p  0.05) in the 2  2  2 (treatment  GD 
sampling time) randomized block ANOVAs. The three-way in-
teraction also attained statistical significance (F(1,28) 4.23; p
0.05) in the analysis of IL-10.
Subsequent post hoc comparisons were then conducted between
the effects of PolyI:C treatment on GD9 (GD9-PolyI:C vs GD9-
saline) and on GD17 (GD17-PolyI:C vs GD17-saline), as well as
between the efficacy of PolyI:C treatment at the two treatment days
(GD9-PolyI:C vs GD17-PolyI:C) at each sampling interval (3 or 6 h
after treatment). The analyses conducted at the earlier sampling in-
terval showed that the PolyI:C-induced increases inmaternal serum
IL-1 and IL-6protein levelsweremostly comparable betweenGD9
and GD17 dams compared with vehicle treatment at the corre-
sponding gestation days, because significant differences were de-
tected between theGD9-PolyI:C andGD9-saline conditions (IL-1,
p  0.01; IL-6, p  0.001) and between the GD17-PolyI:C and
GD17-saline conditions (IL-1, p 0.05; IL-6, p 0.01). In addi-
tion, PolyI:C exposure significantly increased the serum IL-10 and
TNF- contents in both gestation day conditions relative to vehicle
treatment (all p0.05), yet these effects of the immune treatment
were stronger in the GD9-PolyI:C condition compared with the
GD17-PolyI:C condition at 3 h after treatment ( p 0.05 for both
cytokines) (Fig. 7a).
Indeed, the peak IL-10 response to PolyI:C in GD17 dams was
detected at the later sampling time, leading to a significant differ-
ence between the GD17-PolyI:C and GD17-saline conditions
( p  0.01), as well as between the GD9-PolyI:C and GD17-
PolyI:C groups ( p  0.05) (Fig. 7b) at 6 h after treatment. The
serum IL-10 contents in PolyI:C-treated GD9 dams virtually re-
turned to baseline levels at 6 h after treatment, but they were still
significantly increased compared with saline-treated GD9 dams
at this sampling interval ( p  0.05). Similarly, the serum IL-6
contents were still elevated in PolyI:C-treated GD9 and GD17
dams compared with the corresponding vehicle treatment at 6 h
after treatment (GD9-PolyI:C vs GD9-saline, p  0.05; GD17-
Figure 5. Selective enhancement of postnatal brain apoptosis after immune challenge on
late but notmiddle gestation.a– c, e, Distribution of activated caspase-3-immunoreactive cells
in the dorsal dentate gyrus of representative control animals (a) and offspring subjected to
prenatal PolyI:C exposure on GD9 (b) or GD17 (c; higher magnification in e). d, An increase in
activated caspase-3-positive cells was observed exclusively in animals exposed to prenatal
PolyI:C on GD17, whereas the same treatment on GD9 marginally reduced the number of
caspase-3-positive cells compared with control brain tissue, leading to a significant difference
between the twoprenatal PolyI:C conditions.n4 in each treatmentgroup. The values indare
mean SEM. *p 0.05, statistical significance based on Fisher’s LSD post hoc analysis. Scale
bars: a– c, 500m; e, 50m. Cntr, Control.
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PolyI:C vs GD17-saline, p 0.01), but the
PolyI:C-induced IL-6 response at this
sampling interval was stronger in GD17
compared with GD9 dams ( p  0.05). Se-
rum protein levels of IL-1 were below the
detection limit 6 h after PolyI:C treatment,
and no statistically significant differences in
the TNF- response were detected between
the different treatment groups and gestation
day conditions at the latter sampling time.
Fetal brain protein levels
Next, we compared the fetal brain cytokine
responses to maternal PolyI:C or vehicle
administration onmiddle or late gestation
in terms of fetal brain protein levels sam-
pled at 3 or 6 h after treatment. The aver-
age fetal brain cytokine levels obtained per
progeny (n  3–5 fetuses per progeny) in
the two prenatal PolyI:C conditions (GD9
or GD17) were expressed as percentage of
deviation from the mean levels obtained
after saline treatment conducted on the
same gestation day and at the correspond-
ing post-treatment sampling interval (3 or
6 h). At each sample interval, and for each
cytokine protein, independent Student’s t
tests were conducted between effects of
PolyI:C treatment on GD9 (GD9-PolyI:C
vs GD9-saline) and on GD17 (GD17-
PolyI:C vs GD17-saline), as well as be-
tween the efficacy of PolyI:C treatment at
the two treatment days (GD9-PolyI:C vs
GD17-PolyI:C).
Compared with vehicle treatment on
the same day, PolyI:C exposure on GD9
reduced brain contents of IL-10 ( p 0.05) at 3 h after treatment,
but the same treatment conducted on GD17 elevated the brain
levels of this cytokine ( p 0.05) (Fig. 8a), leading to a significant
difference in the relative IL-10 protein contents between PolyI:C-
treated GD9 and GD17 fetal brain tissue ( p 0.001). The PolyI:
C-induced changes in fetal brain IL-10 protein at 3 h after treat-
ment essentially returned to control levels 6 h after treatment
(Fig. 8b). GD9-PolyI:C treatment was also unique in producing a
massive elevation of IL-6 levels at the earlier sampling time rela-
tive toGD9-saline treatment ( p 0.01) andGD17-PolyI:C treat-
ment ( p 0.001) (Fig. 8a). At 6 h after treatment, however, the
PolyI:C-induced elevation of IL-6 levels relative to vehicle treat-
ment was primarily comparable between GD9-PolyI:C and
GD17-PolyI:C groups (GD9, p 0.01; GD17, p 0.05) (Fig. 8b).
In addition, late-pregnancy PolyI:C exposure increased the brain
contents of IL-1 at 3 h after treatment relative to GD17-vehicle
treatment ( p  0.05), but an opposite effect of the immune
treatment was revealed in the GD9 condition ( p 0.01), leading
to a significant difference between the two PolyI:C-exposed ges-
tation day conditions in terms of the relative IL-1 protein con-
tents ( p  0.001) (Fig. 8a). At the later sampling interval, how-
ever, the fetal brain IL-1 levels were increased in GD9-PolyI:C
fetuses compared with GD9-saline treatment ( p  0.01) and
GD17-PolyI:C treatment ( p 0.001) (Fig. 8b). No statistically sig-
nificant differences in the relative TNF- protein levels were de-
tected between the PolyI:C and vehicle groups in both gestation day
conditions, albeit a trend toward increased fetal brain TNF- con-
tentswasdetected inPolyI:C-treatedGD17 fetuses relative toGD17-
vehicle treatment at the later sampling time (Fig. 8b).
Fetal brain gene expression levels
Parallel gene expression analysis of fetal brain tissues also re-
vealed clear differences in cytokine response induced by mid-
versus late-gestational PolyI:C challenge as shown in Figure 9. As
described above, the average fetal brain cytokine levels obtained
per progeny (n  3–4 fetuses per progeny) was submitted to
statistical analyses. At each sample interval, and for each cytokine,
independent Student’s t tests were conducted on the  threshold
cycle (CT) values of the corresponding cytokines to assess the
effects of PolyI:C treatment on GD9 (GD9-PolyI:C vs GD9-
saline) and onGD17 (GD17-PolyI:C vsGD17-saline) and to con-
trast the efficacy of PolyI:C treatment at the two treatment days
(GD9-PolyI:C vs GD17-PolyI:C).
At 3 h after treatment, expression of IL-1 mRNA was sup-
pressed to a similar degree by PolyI:C treatment on GD9 ( p 
0.05) and on GD17 ( p 0.05) compared with vehicle treatment
(Fig. 9a). No effect was observed in IL-6 and IL-10 mRNA levels at
this sampling time. A weak differential response was seen in TNF-
gene expression, with a significant reduction only detected in the
GD17-PolyI:C group ( p 0.05) relative toGD17 vehicle treatment
(Fig.9a).Nodifferences in therelativecytokinegeneexpressionwere
detected between PolyI:C exposure on GD9 and GD17.
The clearest evidence for a critical dependency on the time of
gestational PolyI:C challenge are derived at 6 h after treatment (Fig.
9b). GD17-PolyI:C treatment led to a significant elevation in the
Figure 6. Unaltered postnatal brain gross morphology after prenatal PolyI:C exposure. a, c, e, Photomicrographs of coronal
brain sections of the dorsal hippocampal formation were taken from representative control animals (a) and animals subjected to
prenatal PolyI:C exposure onGD9 (c) or GD17 (e) and visualizedwithNissl/GFAPdouble staining,which stains neuronal cell bodies
and astrocytes, respectively.b,d, f, Note that images on highermagnification (indicated by the squares ina, c, and e) revealed no
differences between prenatal PolyI:C-treated [GD9 (d) and GD17 (f )] and control (Cntr; b) offspring in the neuronal cell numbers
or in the abundance of pyknotic neurons and astrocytes. Scale bars: a, c, e, 500m; b, d, f, 50m.
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gene expression levels of IL-6 ( p  0.01), IL-10 ( p  0.05), and
TNF- ( p  0.01) relative to GD17-saline treatment. In contrast,
GD9-PolyI:C treatment suppressed IL-10 gene expression ( p 
0.01) comparedwithGD9 vehicle treatment and exerted little influ-
ence on the gene expression levels of the other three cytokines (Fig.
9b). This led to the emergence of significant differences between the
PolyI:C-exposedGD9 andGD17 groups in the relative gene expres-
sion levels of IL-1 ( p 0.05), IL-6 ( p 0.01), IL-10 ( p 0.001),
and TNF- ( p 0.001).
Discussion
The present study shows that the time of maternal immune chal-
lenge critically determines the patterns of behavioral abnormali-
ties displayed by the offspring at adult age. PolyI:C challenge on
GD9 suppressed spatial exploration, whereas the same treatment
conducted on GD17 led to perseverative behavior. In each case,
the deficit was not seen in the other treatment condition, thus
demonstrating a cross-double dissociation of the long-term be-
havioral effects associated with maternal immune activation in
mid and late gestation. This extends the single dissociation we
observed previously, in which GD9-PolyI:C but not GD17-
PolyI:C treatment impaired the latent inhibition effect of associa-
tive learning (Meyer et al., 2006). Hence, prenatal immune
activation can lead to the long-termdevelopmentof specific psycho-
pathological traits (Shi et al., 2003; Zucker-
man et al., 2003; Meyer et al., 2005, 2006),
but the specificity of this vulnerability de-
pends on the gestational time windows at
which the maternal host is infected.
Here, we have extended the divergence
in adult psychopathology between mid-
and late-gestational immune activation to
the postnatal emergence of brain neuropa-
thology. The reduction in hippocampal
Reelin expression was most pronounced
after immune challenge atmid-pregnancy,
but the increase in apoptosis was observed
exclusively after late-gestational immune
activation. Both of these histopathological
markers have been implicated in the dis-
ease process of autism and schizophrenia
(Araghi-Niknam and Fatemi, 2003;
Fatemi, 2005; Jarskog et al., 2005). How-
ever, the causes of these structural alter-
ations are not known. When turned to the
fetal developmental stage, we demon-
strated that cytokine-related inflamma-
tory processes in prenatal life are potential
causal agents of postnatal brain histopa-
thology and that the precise outcomes,
similar to the adult psychopathology, de-
pend critically on the time of their acti-
vation. It is important to emphasize that
we did not observe any sign of neurode-
generation that is typified by the pres-
ence of necrotic cell loss and reactive gli-
osis. The absence of gross brain
anatomical alterations agrees well with
the hypothesis that neurodevelopmental
disturbance rather than neurodegenera-
tion is central to the etiopathogenesis
and disease process of schizophrenia and
autism (Weinberger, 1987; Rodier and
Hyman, 1998; Arndt et al., 2005; Miller
et al., 2005; Rapoport et al., 2005).
Reduced Reelin expression in the cortex and hippocampus
has been reported in neonatal offspring from dams having been
infected with influenza virus at mid-pregnancy (Fatemi et al.,
1999). Our data confirm that maternal inflammation in the ab-
sence of a specific viral pathogen is similarly capable to suppress
Reelin expression in the postnatal brain. This further supports
the hypothesis that the critical casual link in the association be-
tween maternal infection during pregnancy and increased risk of
mental disorders in the offspring is the maternal immunological
response to infection (Gilmore and Jarskog, 1997; Shi et al.,
2005).
Among the various immunological events that can be triggered
by infectious agents, the cytokine-associated inflammatory response
may be of particular relevance. Indeed, elevations of inflammatory
cytokines in the maternal host and eventually in the fetal environ-
mentmay represent one of the key events in triggering or precipitat-
ing neurodevelopmental dysfunctions (Gilmore and Jarskog, 1997;
Buka et al., 2001; Brown et al., 2004a). Here, we provide the first
evidence thatmaternal inflammation inducedatdifferent timeswith
divergent pathological outcomes in brain and behavior are also ac-
companied by dissociable cytokine responses in the fetal brain
shortly after the inductionevent.This completes theneurobiological
Figure 7. Comparison of the maternal serum cytokine responses after immune challenge in middle and late gestation. The
maternal administration of PolyI:C (5 mg/kg, i.v.) led to a marked increase in the serum protein levels of IL-1, IL-6, IL-10, and
TNF- in both gestation day conditions relative to vehicle (saline) treatment, and these effects were generally more pronounced
at 3hafter treatment (a) comparedwith the later sampling timeat 6hafter treatment (b). However,whereas thePolyI:C-induced
IL-10 and TNF- responseswere stronger inGD9 comparedwithGD17damsat the earlier sampling interval, higher serumprotein
levels of IL-6 and IL-10 were detected in PolyI:C-exposed GD17 dams compared with the PolyI:C-treated GD9 group at 6 h after
treatment. The number of pregnant dams in each group was 4, except in the following three groups: GD9-PolyI:C/3 h, n 6;
GD17-PolyI:C/3h,n5; GD17-PolyI:C/6h,n5. The levels of IL-1 in vehicle-treated animalswere always below thedetection
limit (ND), regardless of the gestation day condition, and so were the IL-6 levels in the vehicle-treated GD17 group at both
sampling intervals. All values are mean SEM. *p 0.05, **p 0.01, and ***p 0.001, statistical significance based on
Fisher’s LSD post hoc comparisons between the effects of PolyI:C treatment on GD9 (GD9-PolyI:C vs GD9-saline) and on GD17
(GD17-PolyI:C vs GD17-saline), as well as between the efficacy of PolyI:C treatment at the two treatment days (GD9-PolyI:C vs
GD17-PolyI:C) at each sampling interval (3 or 6 h after treatment).
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differentiation between mid- and late-
gestational immune challenge from adult
behavior, postnatal neuroanatomy to fetal
immunology in utero.
Importantly,we reveal that the fetal brain
may directly contribute to the specific
changes in cytokine protein levels after ma-
ternal infection at late but not at mid gesta-
tion. This distinction cannot be attributed to
a differential efficacy of the immune treat-
ment at the two gestation times to induce
significant cytokine responses in the host’s
peripheral immune system, because the ad-
ministration of PolyI:C markedly elevated
maternal serum cytokine levels in bothmid-
dle and late pregnancy (Fig. 7). Moreover,
because the pronounced elevation of pro-
inflammatory cytokine proteins in fetal
brain tissue after immune challenge in mid
gestation was not accompanied by parallel
increases in the mRNA expression levels of
the corresponding genes, the cytokines pro-
tein elevation cannot be readily accounted
by an endogenous increase in cytokine pro-
duction.Rather, the excess cytokineproteins
may be of maternal origin (Zaretsky et al.,
2004) and/or of units of the maternal–fetal
interface, including the placenta (Bowen et
al., 2000). However, the present data do not
exclude thepossibility that alternativemech-
anisms such as variations in post-
transcriptional processing (Clark, 2000),
which are relatively poorly characterized
in the fetal immune system, could also
have contributed to the dissociation of cy-
tokine protein and gene expression levels
in PolyI:C-exposed GD9 fetal brains. In
contrast, immune challenge conducted in
late gestation induced elevations of both
pro- and anti-inflammatory cytokine pro-
teins, with concomitant increases in the relative expression of the
corresponding genes. This latter finding is in full agreement with
a recent study using bacterial endotoxin as an immune-
stimulating agent in pregnant rats at late gestation (Cai et al.,
2000) and readily suggests that the observed increase in specific
cytokines after maternal immune activation on late gestation
might, at least in part, be attributable to endogenous production
by the fetal brain.
The possibility that cytokine-related events in uteromay pre-
cipitate postnatal structural alternations in the brain is high-
lighted by the specific concordant as well as discordant effects
emerged from the comparisons between the cytokine response
patterns after mid- and late-gestational exposure to PolyI:C.
These may be further correlated with the histopatholology ob-
served in the postnatal brain.
Late-gestational immune challenge uniquely activated both
IL-10 and TNF- response in the fetal brain and is associated
with increased postnatal apoptosis. TNF- is a potent inducer of
apoptotic processes in a variety of neuronal and non-neuronal
cells in acute preparations (Tracey and Cerami, 1993). IL-10, on
the other hand, can impede or even prevent the progression of
apoptosis (e.g., via inhibition of TNF- production and activity)
(Bachis et al., 2001). Hence, when the protein levels of IL-10 were
elevated at 3 h after treatment, TNF- gene expression was con-
comitantly reduced. Yet, TNF- gene expression doubled, and its
protein levels rose by 50% by 6 h after treatment, when IL-10 levels
had returned to the baseline level. Although the persistence of the
increase in TNF- gene expression was not precisely determined
here, viral infection on P1 has been reported to induce a sustained
elevation of TNF- levels for 4 weeks (Hornig et al., 1999).
A previous study reported that the prenatal administration of
PolyI:C onmid to late gestation in rats reduced the protein levels of
TNF- in theneonatal brain (Gilmore et al., 2005). This recent find-
ing seems to disagree with the suggestion that increased postnatal
brain apoptosis in GD17-PolyI:C offspring may be directly associ-
ated with the efficacy of late-gestational PolyI:C exposure to induce
significant TNF- responses in the fetal brain.However, the efficacy
of mid- to late-gestational immune challenge in rats to reduce the
TNF-protein contents in the brains of neonateswas not associated
with a similar reduction inTNF- at the fetal brain level (Gilmore et
al., 2005).This indicates that the acute immunological consequences
of thematernal treatmenton the fetal systemmaydiffer considerably
between rats andmice. Conversely, the efficacy of maternal PolyI:C
exposure to increase fetal brain TNF- levels may also be critically
determined by the exact maternal dosage and/or administration
Figure 8. Comparison of the fetal brain cytokine responses after immune challenge in middle and late gestation in terms of
relative protein levels. The average fetal brain cytokine levels obtained per progeny (n 3–5 fetuses per progeny) in the two
prenatal PolyI:C conditions (GD9 or GD17) are expressed as percentage of deviation from the mean levels obtained after saline
treatment conducted on the same gestation day and at the corresponding post-treatment sampling intervals (3 or 6 h). a,
Maternal PolyI:C exposure on GD9 reduced the relative IL-10 protein contents in fetal brain tissue compared with vehicle (saline)
treatment and led to a massive elevation of the relative fetal brain IL-6 levels at 3 h after treatment. Conversely, the same
treatment conducted on GD17 exerted opposite effects on both cytokines at this sampling time. In addition, the relative protein
contents of fetal brain IL-1were only increased aftermaternal PolyI:C treatment onGD17, as opposed to themarginal reduction
observed in GD9-PolyI:C offspring 3 h after treatment.b, At 6 h after treatment, however, amarked elevation IL-1was detected
in the brain of GD9 PolyI:C-exposed offspring, and the relative protein levels of fetal brain IL-6 were increased in PolyI:C-treated
offspring independent of treatment times. The number of pregnant dams in each group was 4, except in the following three
groups: GD9-PolyI:C/3 h, n 6; GD17-PolyI:C/3 h, n 5; GD17-PolyI:C/6 h, n 5. The levels of TNF- on GD9 were below
detection limits 3 h after treatment. All values are mean  SEM. *p  0.05, **p  0.01, and ***p  0.001, statistical
significance based on independent Student’s t tests between the effects of PolyI:C treatment on GD9 (GD9-PolyI:C vs GD9-saline)
and on GD17 (GD17-PolyI:C vs GD17-saline), as well as between the efficacy of PolyI:C treatment at the two treatment days
(GD9-PolyI:C vs GD17-PolyI:C) at each sample interval (3 or 6 h).
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routes. A direct comparison of cytokine events taking place in the
fetal environment after the maternal exposure to inflammatory
agents across different doses would therefore be of great value to fur-
ther consolidate the putative causal relationship between enhanced
TNF-activityduring fetalneurodevelopmentand increased incidence
of postnatal brain apoptosis.
Here, we also demonstrate that both early and late gestational
PolyI:C treatment are equivalently effective in suppressing postnatal
neurogenesis in the hippocampus. In terms of the acute effects of
braincytokines,PolyI:C treatmentoneitherGD9orGD17 increased
IL-6 protein levels in the fetal brain. This parallels reports of a link
between high levels of hippocampal pro-
inflammatory cytokines (including IL-6) in
the hippocampus and reduced neurogenesis
in the dentate gyrus in adult animals
(Vallieres et al., 2002; Monje et al., 2003).
Ourdata thusalsohighlightthepossibilitythat
an acute inflammation of the fetal brain is
capable to undermine an important form of
structural plasticity during postnatal
neurodevelopment.
Hence, there is clear evidence to suggest
that the time of maternal viral-like infection
determines the specificity of the acute cyto-
kine events in the fetus, the developmental
disturbances in the postnatal brain, and the
psychopathological profile in adulthood.
One implication is that the precise timing
may underlie the relationship between the
differing neurodevelopmental vulnerability
associated with in utero infection and the
etiopathogenesis of mental disorders with a
presumed developmental origin. This may
alsodeterminewhether the eventualpsycho-
logical profile falls into one or another sub-
type category, given that different subtypes
of a psychiatric disease are likely to be asso-
ciated with distinct neurodevelopmental
failures (Murray et al., 1992; Rodier andHy-
man, 1998; Sporn et al., 2004).
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